APPLIED PROTEOMICS, INC.

Profile

Company Names

APPLIED PROTEOMICS, INC.

Addresses

3545 JOHN HOPKINS CT., SUITE 150, SAN DIEGO, CA 92121

Phone Numbers

858-999-2800

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$50,363,708.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2013-02-08 
$27,863,715.00 
$27,863,715.00 
$0.00 
Equity 
1
2011-06-07 
$22,499,993.00 
$22,499,993.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DANIEL 
 
ABRUTYN 
EXECUTIVE OFFICER, DIRECTOR
APPLIED PROTEOMICS, INC.
DAVID 
 
AGUS 
EXECUTIVE OFFICER, DIRECTOR
APPLIED PROTEOMICS, INC.   |  CROSSCHX, INC.   |  THRIVE GLOBAL HOLDINGS, INC.   |  OLIVE AI, INC.
JAMES 
 
BLAIR 
DIRECTOR
CELL BIOSCIENCES INC   |  HELIXIS INC   |  ASTUTE MEDICAL, INC.   |  FIVE PRIME THERAPEUTICS INC   |  CODA THERAPEUTICS INC   |  NEUROPACE INC   |  APPLIED PROTEOMICS, INC.   |  WIRELESS DIAGNOSTIC SYSTEMS, INC.   |  OCUNEXUS THERAPEUTICS, INC.   |  INFLAMMX THERAPEUTICS, INC.   |  CARROT LABS INC
JAMES 
C. 
BLAIR 
DIRECTOR
ZOGENIX INC   |  DP VIII ASSOCIATES, L.P.   |  DOMAIN PARTNERS VIII, L.P.   |  INTEGENX INC   |  APPLIED PROTEOMICS, INC.   |  CLOVIS ONCOLOGY, INC.   |  DOMAIN PARTNERS IX, L.P.   |  ATYR PHARMA INC   |  GENE SCIENCES, INC.   |  AXIAL BIOTHERAPEUTICS, INC.   |  CHROMACODE, INC.   |  AXIAL THERAPEUTICS, INC.
DANIEL 
 
HILLIS 
EXECUTIVE OFFICER, DIRECTOR
APPLIED PROTEOMICS, INC.
ERIK 
 
HOLMLIN 
DIRECTOR
GENVAULT CORP   |  APPLIED PROTEOMICS, INC.   |  NANOSPHERE INC
PETER 
 
KLEMM 
EXECUTIVE OFFICER, DIRECTOR
PREDICTIVE BIOSCIENCES, INC   |  APPLIED PROTEOMICS, INC.   |  VIEW POINT MEDICAL, INC.
KOK 
THAY 
LIM 
DIRECTOR
APPLIED PROTEOMICS, INC.   |  CELULARITY INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2013-09-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-02-08 
2012-04-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-06-07 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#